TORONTO, March 18, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced today it has filed its Consolidated Financial Statements and Management's Discussion and Analysis report for the year ended December 31, 2025 with the Canadian securities authorities. These documents may be viewed under the Company's profile at www.sedarplus.com.
"2025 was a milestone year for VitalHub, surpassing $100 million in revenue. In the fourth quarter, we achieved 10% annual organic ARR⁽¹⁾ growth and 24% adjusted EBITDA as a percentage of revenue⁽¹⁾," said Dan Matlow, CEO of VitalHub. "We made significant acquisitions and filled in gaps in our portfolio that support our cross-selling activities globally. Our adjusted EBITDA as a percentage of revenue improved quarter over quarter as we commenced integration of the new acquisitions and we expect to realise further improvement in 2026. We are leveraging AI in our product roadmap and internally from a productivity perspective, as we continue to optimize the organization as one global team. We have a strong balance sheet as we consider acquisition opportunities of all sizes in our core and adjacent geographies. We are excited for the year ahead."
VitalHub's quarterly investor conference call will take place on Thursday, March 19, 2026, at 8:00am EST. To register for the conference call please visit: https://us06web.zoom.us/webinar/register/WN_k8_Av320RimXFXW0CFzQEA
Fourth Quarter 2025 Highlights
ARR⁽¹⁾ as at December 31, 2025 was $96,149,750 as compared to $93,693,789 at September 30, 2025, an increase of $2,455,961 or 3%.Over the previous quarter, ARR movement in Q4 2025 from Q3 2025 was attributable to the following:
Organic growth of $1,881,405 or 2%.
Gain of $574,556 due to fluctuations in foreign exchange rates.
Revenue of $31,390,374 as compared to $20,590,779 in the equivalent prior year period, an increase of $10,799,595 or 52%.
Gross profit as a percentage of revenue was 79% in Q4 2025 as compared to 81% in the equivalent prior year period.
Net income before income taxes of $750,087 as compared to $173,000 in the equivalent prior year period.
Net income of $4,067,533 as compared to $787,244 in the equivalent prior year period.
EBITDA⁽¹⁾ of $3,285,082 as compared to $1,875,370 in the equivalent prior year period.
Adjusted EBITDA⁽¹⁾ of $7,428,508 or 24% of revenue, as compared to $5,046,758 or 25% of revenue in the equivalent prior year period, an increase of $2,381,750 or 47%.
Annual 2025 Highlights
ARR⁽¹⁾ as at December 31, 2025 was $96,149,750 as compared to $71,054,210 at December 31, 2024, an increase of $25,095,540 or 35%.Over the previous year, ARR movement in Q4 2025 from Q4 2024 was attributable to the following:
Organic growth of $7,231,031 or 10%.
Acquisition growth of $15,870,000 or 22%.
Gain of $1,994,509 due to fluctuations in foreign exchange rates.
Revenue of $108,966,918 as compared to $68,594,310 in the equivalent prior year period, an increase of $40,372,608 or 59%.
Gross profit as a percentage of revenue was 80% compared to 81% in the prior year.
Net income before income taxes of $5,901,401 as compared to $5,895,758 in the equivalent prior year period.
Net income of $6,110,963 as compared to $2,999,045 in the equivalent prior year period
EBITDA⁽¹⁾ of $14,634,782 as compared to $9,950,872 in the prior year.
Adjusted EBITDA⁽¹⁾ of $26,554,099 or 24% of revenue, as compared to $17,840,272 or 26% of revenue in the equivalent prior year period, an increase of $8,713,827 or 49%.
Cash on hand and short-term investments as at December 31, 2025 was $119,180,625 compared to $56,574,904 as at December 31, 2024.
(1) Non-IFRS or supplementary financial measure.
Selected Financial Information
Three months ended
Year ended
December 31, 2025
% Revenue
December 31, 2024
% Revenue
Change
December 31, 2025
% Revenue
December 31, 2024
% Revenue
Change
$
$
%
$
$
%
Revenue
31,390,374
100
%
20,590,779
100
%
52
%
108,966,918
100
%
68,594,310
100
%
59
%
Cost of sales
6,486,447
21
%
3,841,539
19
%
(69
%)
21,378,557
20
%
13,099,877
19
%
(63
%)
Gross profit
24,903,927
79
%
16,749,240
81
%
49
%
87,588,361
80
%
55,494,433
81
%
58
%
Operating expenses
General and administrative
6,024,677
19
%
5,442,656
26
%
(11
%)
22,458,560
21
%
15,451,016
23
%
(45
%)
Sales and marketing
2,672,840
9
%
1,685,221
8
%
(59
%)
10,281,531
9
%
6,766,434
10
%
(52
%)
Research and development
8,459,901
27
%
4,189,941
20
%
(102
%)
28,950,760
27
%
15,227,119
22
%
(90
%)
Depreciation of property and equipment
165,796
1
%
123,147
1
%
(35
%)
713,788
1
%
375,838
1
%
(90
%)
Depreciation of right-of-use assets
156,655
0
%
111,156
1
%
(41
%)
557,770
1
%
438,068
1
%
